2024 perioperative management glp-1 receptor agonists anesthesia of patients on agonists: Risks, recommendations, and future directions—A narrative review Perioperative management of long-acting glucagon-like
Description
Although most of the studies reported an association between GLP-1 RA and increased residual gastric contents, evidence linking these medications to a statistically significant rise in regurgitation or aspiration events remains highly inconsistent

Learn why semaglutide is one of the most effective treatments available today.

The first clinical study of an oral small-molecule GLP-1 receptor agonist suggests effective glycemic control and weight loss in patients with type 2 diabetes.

*Based on preclinical studies, can support your bodys natural GLP-1 production

Although glucagon-like peptide-1 receptor agonists (GLP-1 RAs) have demonstrated cardiovascular and kidney benefits in the general population with type 2 diabetes mellitus (T2DM), evidence regarding their effects in diabetic KTRs is limited

Lets prevent avoidable harm